These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9275650)

  • 1. [The application of high molecular weight cytokeratin in differential diagnosis of prostate adenocarcinoma].
    Kong X; Deng F; Wang J
    Zhonghua Bing Li Xue Za Zhi; 1996 Aug; 25(4):199-201. PubMed ID: 9275650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinguishing atrophy and high-grade prostatic intraepithelial neoplasia from prostatic adenocarcinoma with and without previous adjuvant hormone therapy with the aid of cytokeratin 5/6.
    Abrahams NA; Bostwick DG; Ormsby AH; Qian J; Brainard JA
    Am J Clin Pathol; 2003 Sep; 120(3):368-76. PubMed ID: 14502799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycoprotein A-80 in the human prostate: immunolocalization in prostatic intraepithelial neoplasia, carcinoma, radiation failure, and after neoadjuvant hormonal therapy.
    Coogan CL; Bostwick DG; Bloom KJ; Gould VE
    Urology; 2003 Jan; 61(1):248-52. PubMed ID: 12559317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential diagnosis of glandular proliferations in the prostate. A conventional and immunohistochemical approach.
    Helpap B
    Virchows Arch; 1998 Nov; 433(5):397-405. PubMed ID: 9849853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of alpha-methylacyl coenzyme A racemase immunohistochemistry in the diagnosis of prostate cancer: a review.
    Adley BP; Yang XJ
    Anal Quant Cytol Histol; 2006 Feb; 28(1):1-13. PubMed ID: 16566275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic utility of novel immunohistochemical marker ERG in the workup of prostate biopsies with "atypical glands suspicious for cancer".
    He H; Magi-Galluzzi C; Li J; Carver P; Falzarano S; Smith K; Rubin MA; Zhou M
    Am J Surg Pathol; 2011 Apr; 35(4):608-14. PubMed ID: 21383613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate basal cell lesions can be negative for basal cell keratins: a diagnostic pitfall.
    Zhou M; Magi-Galluzzi C; Epstein JI
    Anal Quant Cytol Histol; 2006 Jun; 28(3):125-9. PubMed ID: 16786721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessment of P504S immunohistochemistry in diagnosis and differential diagnosis of prostatic adenocarcinoma].
    Chen GY; Liu LN; Zhou XG; Zhang CH; Huang SF
    Zhonghua Bing Li Xue Za Zhi; 2004 Oct; 33(5):419-23. PubMed ID: 15498210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [P504S and 34betaE12 dual-staining of immunohistochemistry in the diagnosis of prostate cancer].
    Du J; Pei F; Zheng J; Wang K
    Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):311-2. PubMed ID: 16181558
    [No Abstract]   [Full Text] [Related]  

  • 10. Atypical adenomatous hyperplasia of the prostate mimicking adenocarcinoma lesion: case report and literature review.
    Enciu M; Aşchie M; Boşoteanu M; Chisoi A
    Rom J Morphol Embryol; 2012; 53(4):1093-6. PubMed ID: 23303039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p63 protein expression is rare in prostate adenocarcinoma: implications for cancer diagnosis and carcinogenesis.
    Parsons JK; Gage WR; Nelson WG; De Marzo AM
    Urology; 2001 Oct; 58(4):619-24. PubMed ID: 11597556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The utility of basal cell-specific anti-cytokeratin antibody (34 beta E12) in the diagnosis of prostate cancer. A review of 228 cases.
    Wojno KJ; Epstein JI
    Am J Surg Pathol; 1995 Mar; 19(3):251-60. PubMed ID: 7532918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-glutamate receptor 2 as a new potential diagnostic probe for prostatic adenocarcinoma: a pilot immunohistochemical study.
    Hechtman JF; Xiao GQ; Unger PD; Kinoshita Y; Godbold JH; Burstein DE
    Appl Immunohistochem Mol Morphol; 2012 Jul; 20(4):344-9. PubMed ID: 22417861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Histopathological features of prostate cancer].
    Kozuka Y; Imai H; Yamanaka M; Kozuka M; Uchida K; Shiraishi T
    Nihon Rinsho; 2005 Feb; 63(2):231-6. PubMed ID: 15714971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate pathology case study seminar.
    Montironi R; Alexander E; Bostwick DG
    Virchows Arch; 1997 Jan; 430(1):83-94. PubMed ID: 9037320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells.
    Weinstein MH; Signoretti S; Loda M
    Mod Pathol; 2002 Dec; 15(12):1302-8. PubMed ID: 12481011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histomorphological study of prostatic adenocarcinoma and its mimics.
    Mahapatra QS; Mohanty P; Nanda A; Mohanty L
    Indian J Pathol Microbiol; 2019; 62(2):251-260. PubMed ID: 30971549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostatic intraepithelial neoplasia: a lesion that may be confused with cancer on prostatic ultrasound.
    Brawer MK; Rennels MA; Nagle RB; Soiderer MH; Lee F
    J Urol; 1989 Dec; 142(6):1510-2. PubMed ID: 2479777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical basal cell hyperplasia of the prostate.
    Epstein JI; Armas OA
    Am J Surg Pathol; 1992 Dec; 16(12):1205-14. PubMed ID: 1281386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of immunoperoxidase staining with high-molecular-weight cytokeratin in the differential diagnosis of small-acinar lesions of the prostate gland.
    O'Malley FP; Grignon DJ; Shum DT
    Virchows Arch A Pathol Anat Histopathol; 1990; 417(3):191-6. PubMed ID: 1696762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.